# Humacyte, Inc. (HUMAW) — spac [announced]
Source: sec.gov · situation sit_271f6927115f9ce95a7a · public 7266071256997202893 · retrieved 2026-08-19T11:56:27.528Z

## Overview
Humacyte, Inc. is a biological products company developing regenerative medicine solutions; formerly known as Alpha Healthcare Acquisition Corp.

Fresenius Medical Care Holdings, Inc. (FMCH) and Fresenius Medical Care AG (FME AG) reported the completion of a Rule 10b5-1 trading plan established with Citigroup Global Markets Inc. on July 10, 2026. Between August 10 and August 17, 2026, FMCH sold a total of 4,709,500 shares of Humacyte, Inc. common stock at weighted average prices ranging from $0.5547 to $0.7249 per share, generating total proceeds of approximately $2.78 million. As of August 17, 2026, the reporting persons ceased to beneficially own more than 5% of Humacyte's outstanding common stock, having reduced their stake from 13,603,235 shares (4.9% ownership) to below the 5% threshold.

## Terms
- Counterparty: Humacyte, Inc. · Consideration: cash · Stake: 4.9%

## Key dates
- Announced 2026-08-18

## Timeline
- 2026-08-18 · SCHEDULE 13D/A (0001104659-26-098152): SCHEDULE 13D/A - Humacyte, Inc. — *Humacyte, Inc. is a biological products company developing regenerative medicine solutions; formerly known as Alpha Healthcare Acquisition Corp.* Fresenius Medical Care Holdings, Inc. (FMCH) and Fresenius Medical Care AG (FME AG) reported the completion of a Rule 10b5-1 trading plan established with Citigroup Global Markets Inc. on July 10, 2026. Between August 10 and August 17, 2026, FMCH sold a total of 4,709,500 shares of Humacyte, Inc. common stock at weighted average prices ranging from $0.5547 to $0.7249 per share, generating total proceeds of approximately $2.78 million. As of August 17, 2026, the reporting persons ceased to beneficially own more than 5% of Humacyte's outstanding common stock, having reduced their stake from 13,603,235 shares (4.9% ownership) to below the 5% threshold.
  https://www.sec.gov/Archives/edgar/data/1818382/0001104659-26-098152.txt

## Citations
- 0001104659-26-098152 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000110465926098152